Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.
Baggio D, Chung E, Wellard C, Waters N, Cushion T, Chong G, Cochrane T, Cull G, Giri P, Hamad N, Johnston A, Lee D, Murali A, Morgan S, Mulligan S, Talaulikar D, Ratnasingam S, Wood E, Hawkes E, Opat S. Baggio D, et al. Among authors: opat s. Intern Med J. 2024 Jul;54(7):1223-1227. doi: 10.1111/imj.16445. Epub 2024 Jul 7. Intern Med J. 2024. PMID: 38973146
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies.
Blennerhassett R, Hamad N, Grech L, Kwok A, Choi T, Forsyth C, Jagger J, Opat S, Harris S, Chan BA, Nguyen M, Bain N, Day D, Segelov E; CANVACCS Investigators. Blennerhassett R, et al. Among authors: opat s. Acta Haematol. 2024;147(5):543-554. doi: 10.1159/000536548. Epub 2024 Feb 16. Acta Haematol. 2024. PMID: 38290477 Free PMC article.
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, Dickinson M, Prica A, Major A, Hendrickson PG, Hopkins D, Ng A, Casulo C, Baron J, Roberts KB, Al Kendi J, Balogh A, Ricardi U, Torka P, Specht L, De Silva R, Pickard K, Blazin LJ, Henry M, Smith CM, Halperin D, Brady J, Brennan B, Senchenko MA, Reeves M, Hoppe BS, Terezakis S, Talaulikar D, Picardi M, Kirova Y, Fergusson P, Hawkes EA, Lee D, Doo NW, Barraclough A, Cheah CY, Ku M, Hamad N, Mutsando H, Gilbertson M, Marconi T, Viiala N, Maurer MJ, Eichenauer DA, Hoppe RT; GLOW Consortium. Binkley MS, et al. J Clin Oncol. 2024 Jul 1;42(19):2271-2280. doi: 10.1200/JCO.23.01655. Epub 2024 Mar 26. J Clin Oncol. 2024. PMID: 38531001
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study.
Barraclough A, Agrawal S, Talaulikar D, Chong G, Yoo E, Cheah CY, Franco N, Nguyen B, Mutsando H, Tahir F, Trotman J, Huang J, Keane C, Lincoln M, Cochrane T, Johnston AM, Dickinson M, Opat S, McQuilten ZK, Wood EM, St George G, Hawkes EA. Barraclough A, et al. Among authors: opat s. Haematologica. 2024 Oct 1;109(10):3338-3345. doi: 10.3324/haematol.2023.284538. Haematologica. 2024. PMID: 38450504 Free PMC article.
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.
Shadman M, Munir T, Robak T, Brown JR, Kahl BS, Ghia P, Giannopoulos K, Šimkovič M, Österborg A, Laurenti L, Walker PA, Opat SS, Ciepluch H, Greil R, Hanna M, Tani M, Trněný M, Brander D, Flinn IW, Grosicki S, Verner E, Tedeschi A, de Guibert S, Tumyan G, Laribi K, García-Marco JA, Li JY, Tian T, Liu Y, Korolkiewicz R, Szeto A, Tam CS, Jurczak W. Shadman M, et al. Among authors: opat ss. J Clin Oncol. 2024 Dec 8:JCO2402265. doi: 10.1200/JCO-24-02265. Online ahead of print. J Clin Oncol. 2024. PMID: 39647999
Peripheral Neuropathy in the Phase 3 ASPEN Study of Bruton Tyrosine Kinase Inhibitors for Waldenström Macroglobulinemia.
Heyman BM, Opat SS, Wahlin BE, Dimopoulos MAA, Castillo JJ, Tedeschi A, Tam CS, Buske C, Owen RG, Leblond V, Trotman J, Barnes G, Chan WY, Schneider J, Allewelt H, Cohen AC, Matous JV. Heyman BM, et al. Among authors: opat ss. Blood Adv. 2024 Dec 3:bloodadvances.2024014115. doi: 10.1182/bloodadvances.2024014115. Online ahead of print. Blood Adv. 2024. PMID: 39626287
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.
Tatarczuch M, Lewis KL, Gunjur A, Shaw B, Poon LM, Paul E, Ku M, Wong M, Ai S, Beekman A, Ciaccio PRD, Krigstein M, Wight J, Coombes C, Gilbertson M, Tey A, Shortt J, Nagarajan C, Talaulikar D, Hamad N, Ratnasingam S, Ho SJ, Cochrane T, Hawkes EA, Cheah CY, Opat S, Gregory GP. Tatarczuch M, et al. Among authors: opat s. EJHaem. 2024 Jun 21;5(4):709-720. doi: 10.1002/jha2.951. eCollection 2024 Aug. EJHaem. 2024. PMID: 39157596 Free PMC article.
Treatment of relapsed CLL "in the BAAG"?
Opat S. Opat S. Blood. 2024 Jul 18;144(3):243-244. doi: 10.1182/blood.2024024790. Blood. 2024. PMID: 39023867 No abstract available.
146 results